Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127187491 | 12718749 | 1 | I | 2014 | 20160901 | 20160906 | 20160906 | EXP | US-GLAXOSMITHKLINE-US2016128099 | GLAXOSMITHKLINE | 0.00 | F | Y | 0.00000 | 20160906 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127187491 | 12718749 | 1 | PS | LAMICTAL | LAMOTRIGINE | 1 | Oral | 200 MG, BID | 6ZP4126 | 20241 | 200 | MG | TABLET | BID | |||||
| 127187491 | 12718749 | 2 | C | EFFEXOR | VENLAFAXINE HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 127187491 | 12718749 | 3 | C | KLONOPIN | CLONAZEPAM | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127187491 | 12718749 | 1 | Bipolar disorder |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127187491 | 12718749 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127187491 | 12718749 | Dependence | |
| 127187491 | 12718749 | Drug dose omission | |
| 127187491 | 12718749 | Hypertension | |
| 127187491 | 12718749 | Mental disorder |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127187491 | 12718749 | 1 | 1996 | 0 |